Sign In
Buy CRON
$2.71
-0.0200 (-0.733%)
At Close: Jun 03, 2026
7 Growth Stocks That Will Outperform the Markets Through 2028
10:15am, Thursday, 27'th Jun 2024
If we look at high-quality growth stocks, the revenue and EBITDA upside is not just for a year or two. Companies continue to grow at a CAGR of 20% to 30% in the long term.
Cronos Brand Spinach® Celebrates Summer with New Launches
07:30am, Thursday, 27'th Jun 2024
TORONTO, June 27, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc.'s (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) Spinach® brand is expanding its portfolio of award-winning and best-selli
3 Cannabis Stocks to Buy Before Regulations Get Super Friendly
10:50am, Wednesday, 26'th Jun 2024
Investors have long been reading about cannabis stocks to buy. However, stocks in the sector have largely remained speculative plays.
Treasure Hunt: 3 Cannabis Stocks Wall Street Hasn't Discovered Yet
06:53am, Wednesday, 26'th Jun 2024
Cannabis stocks are emerging as fantastic investment options in 2024 for several reasons. One reason is the increased pressure on the American legislature to legalize it.
These Cannabis 3 Stocks Are Set to Soar This Summer and Beyond
08:30am, Tuesday, 25'th Jun 2024
SNDL is expanding in Canada and aiming to offer loans to U.S. players. Green Thumb Industries is already positioned in soon-to-open markets.
Cronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders
04:30pm, Friday, 21'st Jun 2024
TORONTO, June 21, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 20
Legal cannabis sales eat into beer revenue, survey data shows
09:35am, Friday, 21'st Jun 2024
Consumer surveys in Canada and the U.S. show that alcohol consumption is down in areas where adults have the option to consume legal cannabis, Bernstein analyst Nadine Sarwat said in a research note o
Cronos Group Announces Expansion of GrowCo to Fuel Global Growth
08:12am, Thursday, 20'th Jun 2024
TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, announced an expansion of Cronos
3 Meme Stocks Under $10 That Will Double in 3 Months
07:41am, Wednesday, 19'th Jun 2024
Equity markets go through different levels of bullishness. There are times when blue-chips rally and growth stocks are subdued.
June 2024: Canadian Cannabis Stocks with High Potential
09:30am, Tuesday, 18'th Jun 2024
The global cannabis industry and top marijuana stocks are experiencing significant growth, making it an attractive sector for investors. Currently valued at over $20 billion, the industry is projected
Here Is the Best Cannabis Stock to Buy Now
05:45am, Tuesday, 18'th Jun 2024
Marlboro-maker Altria has been exploring ways to diversify beyond tobacco for decades. Despite its early stumbles in cannabis, the tobacco giant still stands as one of the most compelling investing ve
Cronos Group: An Intriguing Value Opportunity
06:11pm, Monday, 17'th Jun 2024
Cronos Group Inc. operates in Canada's recreational market and focuses on medicinal cannabis in lucrative markets like Germany and the U.K. The company is experiencing rapid revenue growth in Canada a
3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024
01:00pm, Monday, 17'th Jun 2024
Investors looking for stocks with millionaire-maker potential must go overweight on growth and penny stocks. When it comes to penny ideas, the thing that comes to mind is speculation or a meme frenzy.
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'
09:26am, Monday, 17'th Jun 2024
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF CNBS, is renowned for recognizing the potential of the cannabis sector early on. In an exclusive interview with Benzinga Canna
3 Penny Stocks Set to Surge 500% by 2026: June Edition
11:02am, Thursday, 13'th Jun 2024
Penny stocks have the tendency to surprise when it comes to delivering stellar returns at the blink of an eye. A good example is Novavax (NASDAQ: NVAX ) that has delivered 203% returns for year-to-dat
